--
You received this message because you are subscribed to the Google Groups "Genome Engineering using CRISPR/Cas Systems" group.
To unsubscribe from this group and stop receiving emails from it, send an email to crispr+un...@googlegroups.com.
For more options, visit https://groups.google.com/d/optout.
Have you tried using Lipofectamine 3000? For the first screen I am preforming with GeCKO v1, I used Lipo3000 which seemed to work quite well. I wonder if you have done any comparisons, which might possibly increase titer levels after transfection. Generally our lab has observed higher transfection efficiency with this product.
By comparing roughly lentiCRISPR v1 and v2 I saw that you inverted some sequences such as the ampicilline resistance gene and modified other sequences. The cas9-puro part and the guide sequence cloning site are still seem the same. Furthermore, you switched from Lucigen E cloni to Endura and grow the bacteria at 32 degrees for library amplification I was wondering whether the modifications of the new lentiCRISPR version and the new protocol reduced recombination problems which scientists experienced in the the first version. How many rounds of library amplification would you suggest doing without losing library representation (and experiencing potential recombination problems)? Do you sequence every time you amplify the library?
Thank you for your explanation. I'm also preparing to use the lentiCRISPRv2 system. I still have some questions regarding the system, I would be grateful if you could provide me with some help.Based on your protocol, you produced virus in T225 flasks with the final volume of 30ml of virus. Can you recommend an approximated range of volume I should use in the functional titering? How do I decide the optimal volume to use in my future experiments?
Currently I'm in possesion of the lentiCRISPRv2 plasmids (already amplified), from what I've read, it is necessary to perform deep sequencing before and after virus production, correct?
I'm thinking of performing the selection on a cancer cell line, I have some confusion about the number of cells to use for the selection process. In your papers you mentioned using a cell number of approximately 400/sgRNA construct to achieve one sgRNA per cell. If I understood correctly, the GeCKOv2 human library has a total of 122,411 sgRNA constructs, then I would need to perform the infection and selection process with about 50,000,000 cells?
Dear Young,
--
You received this message because you are subscribed to the Google Groups "Genome Engineering using CRISPR/Cas Systems" group.
To unsubscribe from this group and stop receiving emails from it, send an email to crispr+un...@googlegroups.com.
To post to this group, send email to cri...@googlegroups.com.